Ostoskori 0 tavarat $0.00
Generic Velpanat
Velpanat
Velpanat is an antiviral combination of sofosbuvir and velpatasvir used to treat chronic hepatitis C virus (HCV) infection across all major genotypes.
Valikoi Annoskoot: 400/100mg
400/100mg
56tabs
Velpanat $3494.39
$2911.99
$52.00 per tab
+ Ilmainen standardi lentoposti palvelu
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $168.00
400/100mg
28tabs
Velpanat $1847.99
$1539.99
$55.00 per tab
+ Ilmainen standardi lentoposti palvelu
+ Paketin toimitus vakuutus
+ Seuraavat tilaukset 10% alennuksella
LISÄÄ OSTOSKORIIN
tallentaa: $0.00
Tilauksesi pakataan turvallinen ja varma ja lähetetään 24 tunnin kuluessa. Tämä on täsmälleen miten pakettisi näyttää (kuvat todellinen merenkulku erä). Se on kooltaan ja ulkoasua säännöllisesti yksityinen kirje (9.4x4.3x0.3 tuumaa tai 24x11x0.7cm) ja se ei paljasta sen sisältöä
Maa Toimitustapa Toimitusajan Hinta  
Toimitus 14-21 päiviä 14.95$ Seuranta # saatavilla 4 päiviä
Toimitus 9-14 päiviä 30$ Seuranta # saatavilla 2 päiviä
Merenkulku maailmanlaajuisesti Luottamuksellisuus ja nimettömyys takaus
Turvallinen ja varma Huomaamaton näköinen paketit
Toimittavat tilauksia sisällä 24 tuntia 100% menestys toimitus
Suosittelut Tuotekuvaus
Tähän tuotteeseen liittyviä arvosteluja ei ole tällä hetkellä saatavilla, voit siis nyt ensimmäisenä lisätä oman arvostelusi tai lukea Suosituksia-sivulta lisää aiheeseen liittyvistä tuotteista.
Lisää Arvostelu

Common use

Velpanat is prescribed for the treatment of chronic hepatitis C in adults. The combination of sofosbuvir (a nucleotide polymerase inhibitor) and velpatasvir (an NS5A inhibitor) works by blocking the virus’s ability to replicate and spread in the body, leading to viral clearance when taken as directed.

Dosage and direction

Velpanat is taken once daily, with or without food. Tablets should be swallowed whole. Treatment duration is typically 12 weeks but may vary depending on hepatitis C genotype, liver condition, or prior therapy. Follow your healthcare provider’s instructions carefully.

Precautions

Inform your doctor if you have a history of liver failure, hepatitis B infection, kidney disease, or if you take medications for heart rhythm issues. Patients co-infected with HBV and HCV may be at risk of HBV reactivation. Do not stop treatment without consulting your doctor.

Contraindications

Velpanat is contraindicated in individuals with known hypersensitivity to sofosbuvir, velpatasvir, or any tablet components. It should not be used with certain medications that significantly reduce velpatasvir levels.

Possible side effect

Common side effects include headache, fatigue, nausea, and insomnia. Less common but serious effects may include slow heartbeat (especially if taken with amiodarone), liver function changes, or allergic reactions. Seek medical attention for severe or unusual symptoms.

Drug interaction

Velpanat may interact with antacids, proton pump inhibitors, rifampicin, St. John’s Wort, certain anticonvulsants, and HIV medications. Some interactions may reduce effectiveness. Always inform your healthcare provider of all medications and supplements you take.

Missed dose

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one. Do not double the dose.

Overdose

Overdose may cause severe headache, fatigue, nausea, or general discomfort. Seek medical attention immediately if an overdose is suspected.

Storage

Store Velpanat at room temperature, away from moisture, heat, and direct sunlight. Keep it in its original bottle and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Suosittelut
David Rochester, Oxford-United Kingdom
Hei, ilokseni voin ilmoittaa, että tilaukseni saapui eilen. Monet kiitokset avustanne!
lue lisää»
Michael Tucker, Stanford
Ryhmänne on ehdottomasti ammattilaisin kaikista, kun vertaan saamiani kokemuksia verkkoapteekeista. Asioin mielelläni kanssanne myös jatkossa ja kehotan myös sukulaisiani ja ystäviäni kääntymään puoleenne.
lue lisää»
Uutiset
Tempted by snacks before bed? Here's why - and what you can do about it
There are biological reasons why you may reach for sweet treats before bed, but you can change the habit.
UK doctor infected with Ebola being treated at London hospital
The doctor tested positive in DR Congo, where there is an outbreak. The government says the risk to the public remains low.
Cocaine overtakes heroin as leading cause of drug deaths in England and Wales
The number of deaths linked to cocaine use in England and Wales has nearly quadrupled in a decade.
'Multi-cancer' blood tests coming to some GP surgeries soon
The aim is to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner.
Toimitus Vaihtoehto